Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in ... - PR Newswire (press release) |
 |
 |
|
PR Newswire (press release) The trial, known as BEACON (Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes: the Occurrence of renal eveNts), is the first multinational, double-blind, placebo-controlled study designed to assess the impact of |
